DDO-3055

CAT: 0804-HY-170915Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-170915Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DDO-3055 is an orally active PHD2 inhibitor that can be used in the research of anemia associated with chronic kidney disease[1].
CAS Number
[1842340-93-5]
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
ClC1=CC=C(OCC#CC2=CC(O)=C(C(NCC(O)=O)=O)N=C2)C=C1
Molecular Formula
C17H13ClN2O5
Molecular Weight
360.75
References & Citations
[1]Xu J, et al. Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. J Med Chem. 2024 Jan 25;67 (2) :1393-1405.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-149863DDO-8926
HY-153331-01DDO-2213
HY-144801ADDO-02005
HY-139301-01DDO-5936
HY-144634-01DDO-7263
HY-132233DDO-2093
HY-147125DDO-6600
HY-169947-01DDO-6079
HY-170668DDO-02267
HY-155489-01DDO-2728

Alternative Products

CatalogName
T205089-01DDO-3055
CSB-CL006593HUDDO
588344DDO (DASOX, DDO-1, DDO-2, FLJ45203, aspartic oxidase)
245248DDO (D-Aspartate Oxidase, DASOX, DDO-1, DDO-2, FLJ45203)
034538DDO, ID (DDO, D-aspartate oxidase)
MBS3613714-01DDO-5936
560153-01DDO (FITC)
MBS7048013-01DDO Antibody
T207588-01DDO-6691
T62283-01DDO-02005

Popular Products